Skip to content

Role of shirish sindhuwar ointment and panchkarma in Irritant contact dermatitis

â??Randomized comparative study of Vishghna Ointment (alone and after Virechan karma) in management of Vicharchika w.s.r. to Irritant Contact Dermatitisâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017639
Enrollment
30
Registered
2019-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L249- Irritant contact dermatitis, unspecified cause

Interventions

Intervention1: Group A: 15 clinically diagnosed & registered patients of ICD will be treated by virechna with Triphala, Nishoth or Dantimool, and Vishghna ointment for external application. Control In

Sponsors

Uttrakhand Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a). Age group between 16-60 years. b). Chronicity not more than 2 years. c). Patient fulfilling the diagnostic criteria of ICD.

Exclusion criteria

Exclusion criteria: a) Patient suffering from severe chronic illness. b) Patient suffering with chronic infectious disorder. c) Known case of other allergic disorder.

Design outcomes

Primary

MeasureTime frame
To assess the effect of therapy,objectively all sign and symptom were given scoring depending upon their severity. Complete remission-100% Moderate improvement-75-99% Mild improvement-25-49% No improvement-0-24%Timepoint: After 45 days To assess the effect of therapy,objectively all sign and symptom were given scoring depending upon their severity. Complete remission-100% Moderate improvement-75-99% Mild improvement-25-49% No improvement-0-24%

Secondary

MeasureTime frame
Exacerbation in sign and symptomsTimepoint: 45 days

Countries

India

Contacts

Public ContactAnkur Mishra

Rishikul campus, haridwar, uttrakhand ayurved university

ankur.ayurveda1902@gmail.com9456567261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026